The Inconclusive Results of the Studies on Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease

Abstract

Get full access to this article

View all access options for this article.

References

Koza

Senocak

. The inconclusive results of the studies on glycoprotein IIIa platelet receptor gene polymorphism and coronary artery disease: an area of darkness. Angiology. 2015;66 (1):86–87.

Verdoia

Cassetti

Schaffer

. Relationship between glycoprotein IIIa platelet receptor gene polymorphism and coronary artery disease. Angiology. 2015;66 (1):79–85.

De Luca

Santagostino

Secco

. Platelet-large cell ratio and the extent of coronary artery disease: results from a large prospective study. J Thromb Thrombolysis. 2010;30 (4):426–433.

De Luca

Venegoni

Iorio

. Platelet distribution width and the extent of coronary artery disease: results from a large prospective study. Platelets. 2010;21 (7):508–514.

De Luca

Santagostino

Secco

. Mean platelet volume and the extent of coronary artery disease: results from a large prospective study. Atherosclerosis. 2009;206 (1):292–297.

Roberts

. Genetics

of coronary artery disease. Circ Res. 2014;114 (12):1890–1903.

Weiss

Bray

Tayback

. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med. 1996;334 (17):1090–1094.

Ardissino

Mannucci

Merlini

. Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood. 1999;94 (1):46–51.

Garcia-Ribes

Gonzalez-Lamuño

Hernandez-Estefania

. Polymorphism of the platelet glycoprotein IIIa gene in patients with coronary stenosis. Thromb Haemost. 1998;79 (6):1126–1129.

10.

Abboud Abboud

Ghazouani

Ben-Hadj-Khalifa

. Human platelet alloantigens HPA-1, HPA-2, and HPA-3 polymorphisms associated with extent of severe coronary artery disease. J Thromb Thrombolysis. 2010;29 (4):409–415.

11.

Böttiger

Kastrati

Koch

. HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost. 2000;83 (4):559–562.

12.

Lagercrantz

Bergman

Lundman

. No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction. Blood Coagul Fibrinolysis. 2003;14 (8):749–753.

13.

Alecsik

Juneja

Folsom

. Platelet Pl(A2) allele and incidence of coronary heart disease: results from the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 2000;102 (16):1901–1512.

14.

Di Castelnuovo

de Gaetano

Donati

Iacoviello

. Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis. Thromb Haemost. 2001;85 (4):626–633.

15.

Liu

Higgins

. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet. 2006;367 (9511):651–658.

16.

Bonello

Tantry

Marcucci

. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010;56 (12):919–933.

17.

Verdoia

Pergolini

Camaro

. PlA(1)/PlA(2) polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty. Blood Coagul Fibrinolysis. 2013;24(4):411–418.